v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash flows from operating activities:    
Net loss $ (2,123,226) $ (1,679,053)
Adjustments to reconcile net loss to net cash used in operating activities:    
Amortization 1,017,811
Common Stock issued for services 85,150 117,611
Stock Compensation Expense 3,792,000 602,000
Units in unconsolidated affiliate for services (500,000)
Non-cash lease expense 10,802
Changes in operating assets and liabilities:    
Accounts Receivable (2,846,500)
Prepaid expenses and other assets 129,319 50,000
Inventory (28,000)
Accounts payable and accrued liabilities (335,124) 85,040
Accounts payable and accrued liabilities – Related Parties (443,808) 364,494
Deposits (15,321)
Operating lease liabilities (2,078)
Deferred revenue (1,193,500)
Net cash used in operating activities (2,452,475) (459,908)
Cash flows from financing activities:    
Cash from Sale of common stock, pre-funded warrants and warrants 13,600,270
Cost of Financing (1,346,157)
Proceeds from (Payments to) Short term Loan – Related Parties (825,700) 415,300
Deferred Offering Costs (90,135)
Net cash provided by financing activities 11,428,413 325,165
Net increase (decrease) in cash and cash equivalents 8,975,938 (134,743)
Cash and cash equivalents at beginning of period 401,203 156,087
Cash and cash equivalents at end of period 9,377,141 21,344
Supplementary disclosure of non-cash operating, investing and financing activities:    
Common stock issued for accounts payable 103,401
Operating lease right-of-use assets in exchange for operating lease liabilites 340,273
Deferred offering costs charged to cost of financing in equity upon completion of the February 2026 offering 393,203
Noncash offering cost - Underwriter Warrants issued in February 2026 offering $ 298,945

Source

10-Q XBRL Zip